Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLGW) Tax Provisions (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Tax Provisions for 2 consecutive years, with $1600.0 as the latest value for Q2 2017.

  • Quarterly Tax Provisions changed N/A to $1600.0 in Q2 2017 from the year-ago period, while the trailing twelve-month figure was $1098.0 through Dec 2017, down 47.91% year-over-year, with the annual reading at $1600.0 for FY2021, 0.0% changed from the prior year.
  • Tax Provisions for Q2 2017 was $1600.0 at Bone Biologics, up from -$502.0 in the prior quarter.
  • The five-year high for Tax Provisions was $1600.0 in Q1 2016, with the low at -$502.0 in Q4 2016.